Editorial Policy


 Sudan Heart Journal (SHJ) endorses the World Association of Medical Editors (WAME) Policy Statement on Geopolitical Intrusion on Editorial Decisions. SHJ also endorses the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. .

The aim of the journal is to facilitate medical education through the publication and dissemination of quality original papers and promote medical knowledge to enable cardiologist to keep up to date with developments in their specialty, particularly those which may impact upon their practice. The journal also reports on Sudan Heart Society activities such as symposia, conferences and continuous medical education programs.

Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance, tables, or figures has been or will be published or submitted elsewhere before appearing in the Journal. Review articles, original papers, case reports, cardiology images, clinical Quiz, commentaries and letter to the editor are accepted.

Authorship and contributorship

We support the ICJME’s statement on authors and contributors:

Authorship credit should be based on:

  1. Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
  2. Drafting the article or revising it critically for important intellectual content; and
  3. Final approval of the version to be published.

When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript (3). These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name.

  1. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
  2. All persons designated as authors should qualify for authorship, and all those who qualify should be listed.
  3. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
  4. Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship/contributorship.
  5. The group should jointly make decisions about contributors/authors before submitting the manuscript for publication. The corresponding author/guarantor should be prepared to explain the presence and order of these individuals. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship.
  6. Contributors Listed in Acknowledgments: All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chairperson who provided the general support.

Plagiarism

The Editors will not accept plagiarism and articles shown to have been substantially compiled from previously published works by the same or other authors will be strongly rejected.

SPECIAL CASES

Clinical Trials

The ICMJE requires that “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” must be registered before the start of patient enrollment. Trials in which the primary goal is to determine pharmacokinetics are exempt. To be acceptable, a registry must be owned by a non-for-profit entity, be publicly accessible, and contain the twenty fields proposed by the World Health Organization. View a list of acceptable registries on the ICMJE website.
Each manuscript will be checked upon submission to determine whether the study needed registration, and if registered, whether the registration is complete and meaningful.

Conflict of interest

Authors of research articles should disclose at the time of revision any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure statement will appear with the article.
Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any significant financial interest in a company (or its competitor) that makes a product discussed in the article.

Patient consent

Patient consent is necessary for any case details or images where the specific information about a condition and the patient’s age, gender and treating hospital make it impossible to guarantee anonymity. We require patients’ written consent for the publication of any potentially identifiable medical information, including all Cases of the Quarter submissions.

If a submitted paper contains any potentially identifiable medical information, authors are required to supply a signed statement that they have obtained the patient’s written consent to publish this material. If authors have not obtained this written consent already, the editorial office can supply a JRCPE patient consent form (for the author’s and patient’s use only – not to be sent back to the editorial office).

Declarations of interest

All participants in the peer-review and publication process must disclose all relationships that could be viewed as potential conflicts of interest. This information is held centrally and can be made available upon request.

All authors are required specifically to declare relevant interests (including potential or actual personal, financial or political interests) and this information is published in the JRCPE. The ICMJE developed a uniform disclosure form that we have adopted. It is available here: http://www.icmje.org/coi_disclosure.pdf

Copyright transfer form

Authors should sign a copyright transfer form and assign copyright to SHJ.

Ethics

The editors of the SHJ view alleged, or suspected medical or biomedical research misconduct (including plagiarism and duplicate publication) as a serious offence and will refer suspected cases of misconduct to the appropriate bodies.

Human and animal experimentation/the Declaration of Helsinki

When reporting experiments on humans, authors should state whether their procedures were in accordance with the ethical standards of the responsible institutional and national ethics committee and with the Declaration of Helsinki. If in doubt whether the research was conducted in accordance with the Helsinki Declaration, authors must explain the reasons for their approach and show that their institutional review body explicitly approved the doubtful aspects of their study. When reporting experiments on animals, authors should state whether the institutional and national guidelines for the care and use of laboratory animals were followed.

 

 

 

 

 

Sources

International Committee of Medical Journal Editors (ICMJE), http://www.icmje.org/.

Journal of Royal College of Physicians, Edinburgh

New England Medical Journal